Gpi achieved positive results abroad in Q2 2024, securing new contracts worth € 7.3 million, continuing the performance from Q1. The Group’s global presence is expanding.
Among the main results, the Riedl Phasys robotic warehouse for pharmacies confirms itself as one of the leading technological products for the Group’s expansion into new markets: contracts worth 600 thousand euros have been secured in new countries (Finland, Iceland).
The transfusion system suite Gpi4Med.BLOOD closed contracts worth €1.7 million. The Philippine Red Cross joined the client portfolio, with 130 installations across the Pacific archipelago.
Excellent results for Evolucare as well, with nearly €5 million in new contracts in Q2, driven by positive sales of software supporting people with disabilities.
